The Undersea
and Hyperbaric Medical Society (UHMS) approves of several applications of hyperbaric
oxygen. The following indications are defined
by the UHMS Hyperbaric Oxygen Therapy Committee. These are recognized by
Medicare in the United States as approved conditions:
- Air or gas embolism
- UHMS
- Carbon monoxide poisoning
- UHMS
-- Carbon monoxide poisoning complicated by cyanide poisoning
- UHMS
- Clostridal myositis
and myonecrosis (gas gangrene) - UHMS
- Crush injury, compartment
syndrome, and other acute traumatic ischemias - UHMS
- Decompression sickness
- UHMS
- Arterial Insufficiencies
-- Central retinal artery occlusion - UHMS
-- Enhancement of healing in selected problem wounds - UHMS
- Severe Anemia - UHMS
- Intracranial abscess
- UHMS
- Necrotizing soft tissue
infections - UHMS
- Osteomyelitis (refractory)
- UHMS
- Delayed radiation injury
(soft tissue and bony necrosis) - UHMS
- Compromised skin grafts
and flaps - UHMS
- Acute thermal burn
injury - UHMS
Other applications
of HBOT that have been reported include:
Doctors
in the United States, either M.D., or D.O., are lawfully allowed to prescribe
HBOT for off-label conditions, including Lyme Disease, stroke, and migraines.
|
